Salahuddin

Mohammed

Education

• Ph.D. in Pharmaceutical Sciences, Pharmacology- University of Mississippi, Department of BioMolecular Sciences, USA, 2022.
• M.Sc. in Pharmacology - Aston University, College of Life & Health Sciences, Birmingham, 2010.
• B.S. Pharmacy, Osmania University, India, 2008.

Dr Mohammed uses behavioral pharmacological techniques in mice models and also has expertise in self-report methods (questionnaires, interviews) and online data collection for assessing affective and cognition related pathologies.

Experience

Graduate Research Assistant

Department of BioMolecular Sciences, University of Mississippi, Oxford, USA.
Project: Understanding neuroendocrine, cellular & molecular mechanisms of neuroHIV, and addiction.

Postdoctoral Associate

Yale School of Medicine, Department of Psychiatry, New Haven, USA.
Project:  Exploration of genomic signatures in neuropsychiatric diseases like PTSD and depression.

Research Interests

(1) Neurobiology of stress-related and addictive disorders: Screening novel therapeutics to rescue affective, cognitive, and reward-related pathology associated with brain dysfunction in addiction and neurodegenerative disease states. 

(2) Predictors and correlates in stress related pathologies: Exploration of correlates, psychometrics and risk factors in various sleep, stress-related and addictive- behavioral states.

Publications

Current Most Relevant Contributions: 
PubMed: https://www.ncbi.nlm.nih.gov/myncbi/1dQSgFRdi-tQs8/bibliography/public/ 
Google Scholar: https://scholar.google.com/citations?user=8wO-6FEAAAAJ&hl=en 

1. Akins N, Salahuddin MF, Pandey P, Seong Jong K, Mahdi, F, Khan, MI, Moss, E, Worth, C, Keane M, Chittiboyina A, Doerksen R, Paris J, Le H. Alleviation of Cocaine Withdrawal and Pertinent Interactions Between Salvinorin-Based Antagonists and Kappa Opioid Receptor. ACS Chem Neurosci 2023; DOI: 10.1021/acschemneuro.2c00806
2. Salahuddin MF, Manzar MD, Unissa A, Pandi-perumal SR, Bahammam AS. The global shortage of essential drugs during the COVID-19 pandemic: evidence based on aggregated media and social media reports. Journal of Nature of Science and Medicine, 2022; 5(1): 23-28. DOI: 10.4103/jnsm.jnsm_61_21    
3. Manzar MD, Kashoo FZ, Hassen HY. Albougami A, Noohu MM, Salahuddin MF, Shah SA, Mir SA, Pandi-perumal SR, Bahammam AS. Metacognition Mediates the Association Between Drug Dependence and Sleep Disturbances: Cross-Sectional Findings Among Khat-Chewing Polysubstance Users. Int J Ment Health Addiction, 2022. https://doi.org/10.1007/s11469-022-00924-9
4. Manzar MD, Alghadir AH, Khan M, Salahuddin MF, Hassen HY, Almansour AM, Nureye D, Tekalign E, Shah SA, Pandi-perumal SR, Bahammam AS.  Poor Sleep in Community-Dwelling Polysubstance Users: Association With Khat Dependence, Metacognition, and Socio-Demographic Factors. Frontiers in Psychiatry, 2022; 13:792460. DOI: https://doi.org/10.3389/fpsyt.2022.792460 
5. Salahuddin MF, Qrareya AN, Mahdi F, Jackson D, Foster M, Vujanovic T, Box JG, Paris JJ. Combined HIV-1 Tat and oxycodone activate the hypothalamic-pituitary-adrenal and -gonadal axes and promote psychomotor, affective, and cognitive dysfunction in female mice. Hormones and Behavior, 2020; 119:104649. PMID: 31821792
6. Salahuddin MF, Qrareya AN, Mahdi F, Li J, Le H, Paris JJ. Allopregnanolone and NeuroHIV: Potential Benefits of Neuroendocrine Modulation in the Era of Antiretroviral Therapy. J Neuroendocrinol. https://doi.org/10.1111/jne.13047
7. Salahuddin MF, Manzar MD, Hassen HY, Unissa A, Hameed UA. Spence DW, Pandi-Perumal SR. Prevalence and Predictors of Neurocognitive Impairment in Ethiopian Population Living with HIV. HIV/AIDS - Research and Palliative Care. 2020,12: 559–572. PMCID: PMC7568595
8. Paris JJ, Liere P,  Kim S, Mahdi F , Buchanan ME , Nass SR, Qrareya AN,  Salahuddin MF, Pianos A, Fernandez N, Shariat-Madar Z, Knapp PE, Schumacher M, Hauser KF. Pregnane steroidogenesis is altered by HIV-1 Tat and morphine: Physiological allopregnanolone is protective against neurotoxic and psychomotor effects. Neurobiology of Stress. 2020; 12: 100211. PMID: 32258256
9. Salahuddin MF, Manzar MD, Pandi-perumal SR, Bahammam AS. Emerging challenges in COVID-19 with substance use disorders. Addictive Disorders & Their Treatment., 2021 - DOI: 10.1097/ADT.0000000000000266

Professional Affiliations & Memberships

Associate Editor: All Life Pharmacology & Pharmaceutics Section (Taylor & Francis Publishing House) & Journal of Concurrent Disorders

Editorial Board Member: BMC Psychiatry, BMC Research Notes

American Association of Colleges of Pharmacy: Board Member

American Chemical Society: Certified Peer Reviewer

Elsevier: Certified Peer Reviewer